Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRODIGE 11: Sorafenib + Pravastatin in HCC
NCT01075555Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Feb 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pravastatin in hepatocellular carcinoma (HCC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Feb 2010; status: completed.
02
Drugs
pravastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01075555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075555.